195 related articles for article (PubMed ID: 19540723)
1. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.
Zhang XY; Chen DC; Xiu MH; Wang F; Qi LY; Sun HQ; Chen S; He SC; Wu GY; Haile CN; Kosten TA; Lu L; Kosten TR
Schizophr Res; 2009 Sep; 113(2-3):151-7. PubMed ID: 19540723
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
Zhang XY; Chen DC; Xiu MH; Yang FD; Tan YL; He S; Kosten TA; Kosten TR
Schizophr Res; 2013 Feb; 143(2-3):301-6. PubMed ID: 23238053
[TBL] [Abstract][Full Text] [Related]
3. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology.
Xiu MH; Chen DC; Wang D; Zhang K; Dong A; Tang W; Zhang F; Liu LJ; Liu JH; Liu HB; Yang FD; Kosten TR; Zhang XY
J Psychiatr Res; 2012 Aug; 46(8):1093-8. PubMed ID: 22647522
[TBL] [Abstract][Full Text] [Related]
4. Increased plasma levels of thioredoxin-1 in patients with first episode psychosis and long-term schizophrenia.
Owe-Larsson B; Ekdahl K; Edbom T; Osby U; Karlsson H; Lundberg C; Lundberg M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1117-21. PubMed ID: 21457743
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: inverse association with positive symptoms.
Wu Z; Zhang XY; Wang H; Tang W; Xia Y; Zhang F; Liu J; Fu Y; Hu J; Chen Y; Liu L; Chen DC; Xiu MH; Kosten TR; He J
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):34-8. PubMed ID: 21896300
[TBL] [Abstract][Full Text] [Related]
6. Increased serum S100B in never-medicated and medicated schizophrenic patients.
Zhang XY; Xiu MH; Song C; Chen DC; Wu GY; Haile CN; Kosten TA; Kosten TR
J Psychiatr Res; 2010 Dec; 44(16):1236-40. PubMed ID: 20510426
[TBL] [Abstract][Full Text] [Related]
7. Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment.
Genc A; Kalelioglu T; Karamustafalioglu N; Tasdemir A; Gungor FC; Genc ES; Incir S; Ilnem C; Emul M
Psychiatry Clin Neurosci; 2015 Jun; 69(6):344-50. PubMed ID: 25297388
[TBL] [Abstract][Full Text] [Related]
8. Serum Levels of Thioredoxin Are Associated with Stroke Risk, Severity, and Lesion Volumes.
Wu MH; Song FY; Wei LP; Meng ZY; Zhang ZQ; Qi QD
Mol Neurobiol; 2016 Jan; 53(1):677-685. PubMed ID: 25520003
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin is a novel diagnostic and prognostic marker in patients with ischemic stroke.
Qi AQ; Li Y; Liu Q; Si JZ; Tang XM; Zhang ZQ; Qi QD; Chen WB
Free Radic Biol Med; 2015 Mar; 80():129-35. PubMed ID: 25555670
[TBL] [Abstract][Full Text] [Related]
10. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
11. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
Chen DC; Wang J; Wang B; Yang SC; Zhang CX; Zheng YL; Li YL; Wang N; Yang KB; Xiu MH; Kosten TR; Zhang XY
Psychopharmacology (Berl); 2009 Dec; 207(3):375-80. PubMed ID: 19787338
[TBL] [Abstract][Full Text] [Related]
12. Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology.
Xiu MH; Yang GG; Tan YL; Chen DC; Tan SP; Wang ZR; Yang FD; Okusaga O; Soares JC; Zhang XY
Schizophr Res; 2014 Jun; 156(1):9-14. PubMed ID: 24766914
[TBL] [Abstract][Full Text] [Related]
13. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia.
Borovcanin M; Jovanovic I; Dejanovic SD; Radosavljevic G; Arsenijevic N; Lukic ML
Psychoneuroendocrinology; 2015 Jun; 56():143-7. PubMed ID: 25827958
[TBL] [Abstract][Full Text] [Related]
14. Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia.
Fu YY; Zhang T; Xiu MH; Tang W; Han M; Yun LT; Chen DC; Chen S; Tan SP; Soares JC; Tang WJ; Zhang XY
Schizophr Res; 2016 Oct; 176(2-3):196-200. PubMed ID: 27237600
[TBL] [Abstract][Full Text] [Related]
15. The interplay between BDNF and oxidative stress in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis.
Jikimoto T; Nishikubo Y; Koshiba M; Kanagawa S; Morinobu S; Morinobu A; Saura R; Mizuno K; Kondo S; Toyokuni S; Nakamura H; Yodoi J; Kumagai S
Mol Immunol; 2002 Feb; 38(10):765-72. PubMed ID: 11841836
[TBL] [Abstract][Full Text] [Related]
17. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
[TBL] [Abstract][Full Text] [Related]
18. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection.
Kato A; Odamaki M; Nakamura H; Yodoi J; Hishida A
Kidney Int; 2003 Jun; 63(6):2262-8. PubMed ID: 12753316
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution.
Martinez-Pinna R; Lindholt JS; Blanco-Colio LM; Dejouvencel T; Madrigal-Matute J; Ramos-Mozo P; Vega de Ceniga M; Michel JB; Egido J; Meilhac O; Martin-Ventura JL
Atherosclerosis; 2010 Sep; 212(1):333-8. PubMed ID: 20609439
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum thioredoxin 1 levels in patients with acute pancreatitis.
Ohashi S; Nishio A; Nakamura H; Kido M; Kiriya K; Asada M; Tamaki H; Fukui T; Kawasaki K; Watanabe N; Yodoi J; Okazaki K; Chiba T
Pancreas; 2006 Apr; 32(3):264-70. PubMed ID: 16628081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
